Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
J Bourhis, J Overgaard, H Audry, KK Ang, M Saunders… - The Lancet, 2006 - thelancet.com
Background Several trials have studied the role of unconventional fractionated radiotherapy
in head and neck squamous cell carcinoma, but the effect of such treatment on survival is …
in head and neck squamous cell carcinoma, but the effect of such treatment on survival is …
Radiation response of the central nervous system
TE Schultheiss, LE Kun, KK Ang… - International Journal of …, 1995 - Elsevier
This report reviews the anatomical, pathophysiological, and clinical aspects of radiation injury
to the central nervous system (CNS). Despite the lack of pathognomonic characteristics for …
to the central nervous system (CNS). Despite the lack of pathognomonic characteristics for …
[PDF][PDF] American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer
…, WM Mendenhall, DJ Adelstein, KK Ang… - Journal of clinical …, 2006 - Citeseer
… Garden AS, Morrison WH, Ang KK, et al: Hyperfractionated radiation in the treatment of
squamous cell carcinomas of the head and neck: A comparison of two fractionation …
squamous cell carcinomas of the head and neck: A comparison of two fractionation …
[HTML][HTML] Human papillomavirus and survival of patients with oropharyngeal cancer
Background Oropharyngeal squamous-cell carcinomas caused by human papillomavirus (HPV)
are associated with favorable survival, but the independent prognostic significance of …
are associated with favorable survival, but the independent prognostic significance of …
[HTML][HTML] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
…, N Amellal, EK Rowinsky, KK Ang - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a multinational, randomized study to compare radiotherapy alone
with radiotherapy plus cetuximab, a monoclonal antibody against the epidermal growth …
with radiotherapy plus cetuximab, a monoclonal antibody against the epidermal growth …
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard …
… (KK Fu and KK Ang) with the RTOG staff. Calibration of each institution’s equipment was
obtained from the Radiological Physics Center at the University of Texas MD Anderson Cancer …
obtained from the Radiological Physics Center at the University of Texas MD Anderson Cancer …
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma
KK Ang, BA Berkey, X Tu, HZ Zhang, R Katz… - Cancer research, 2002 - AACR
A correlative study was performed to address the impact of epidermal growth factor receptor
(EGFR) overexpression on survival and pattern of failure in patients with advanced head …
(EGFR) overexpression on survival and pattern of failure in patients with advanced head …
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between …
…, J Zhu, H Youssoufian, EK Rowinsky, KK Ang - The lancet …, 2010 - thelancet.com
Background Previous results from our phase 3 randomised trial showed that adding
cetuximab to primary radiotherapy increased overall survival in patients with locoregionally …
cetuximab to primary radiotherapy increased overall survival in patients with locoregionally …
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC …
…, JR Jacobs, J Jassem, KK Ang… - Head & Neck …, 2005 - Wiley Online Library
Background. In 2004, level I evidence was established for the postoperative adjuvant
treatment of patients with selected high‐risk locally advanced head and neck cancers, with the …
treatment of patients with selected high‐risk locally advanced head and neck cancers, with the …
[HTML][HTML] Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis
…, JS Cooper, A Forastiere, KK Ang - Journal of Clinical …, 2008 - ncbi.nlm.nih.gov
Purpose Concurrent chemoradiotherapy (CCRT) for squamous cell carcinoma of the head
and neck (SCCHN) increases both local tumor control and toxicity. This study evaluates …
and neck (SCCHN) increases both local tumor control and toxicity. This study evaluates …